IRadimed (Germany) Performance
| 46K Stock | 83.50 3.00 3.47% |
On a scale of 0 to 100, IRadimed holds a performance score of 11. The company retains a Market Volatility (i.e., Beta) of 0.34, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, IRadimed's returns are expected to increase less than the market. However, during the bear market, the loss of holding IRadimed is expected to be smaller as well. Please check IRadimed's sortino ratio, semi variance, and the relationship between the standard deviation and value at risk , to make a quick decision on whether IRadimed's current trending patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in IRadimed are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, IRadimed unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0081 | Payout Ratio 0.3886 | Forward Dividend Rate 0.68 | Ex Dividend Date 2026-02-23 |
1 | How IRADIMED CORPORATION stock reacts to job market data - 2025 Bull vs Bear High Accuracy Investment Signals - B NI V | 11/27/2025 |
2 | IRADIMED Assessing Valuation After Strong MultiYear Share Price Gains - simplywall.st | 12/16/2025 |
3 | iRadimed Hits New 12-Month High - Still a Buy - MarketBeat | 12/29/2025 |
4 | Momentum Shift Can IRADIMED CORPORATION stock beat market expectations this quarter - Watch List AI Driven Stock Reports - moha.gov.vn | 01/02/2026 |
5 | Will IRADIMED CORPORATION stock maintain momentum in 2025 - Market Volume Summary Weekly Watchlist of Top Performers - ulpravda.ru | 01/08/2026 |
6 | IRadimed Corporation Accelerating with Solid Capital Return - Yahoo Finance Canada | 01/19/2026 |
7 | Insider Transaction Roger E Susi Sells 503K Worth Of iRadimed Shares - Benzinga | 01/28/2026 |
8 | Uncovering Potential iRadimeds Earnings Preview - Benzinga | 02/09/2026 |
9 | Why Iradimed Stock Soared Today - AOL.com | 02/13/2026 |
IRadimed |
IRadimed Relative Risk vs. Return Landscape
If you would invest 7,112 in IRadimed on November 17, 2025 and sell it today you would earn a total of 1,238 from holding IRadimed or generate 17.41% return on investment over 90 days. IRadimed is generating 0.2809% of daily returns and assumes 1.9027% volatility on return distribution over the 90 days horizon. Simply put, 17% of stocks are less volatile than IRadimed, and 95% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
IRadimed Target Price Odds to finish over Current Price
The tendency of IRadimed Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 83.50 | 90 days | 83.50 | about 24.35 |
Based on a normal probability distribution, the odds of IRadimed to move above the current price in 90 days from now is about 24.35 (This IRadimed probability density function shows the probability of IRadimed Stock to fall within a particular range of prices over 90 days) .
IRadimed Price Density |
| Price |
Predictive Modules for IRadimed
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as IRadimed. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of IRadimed's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
IRadimed Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. IRadimed is not an exception. The market had few large corrections towards the IRadimed's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold IRadimed, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of IRadimed within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.22 | |
β | Beta against Dow Jones | 0.34 | |
σ | Overall volatility | 4.56 | |
Ir | Information ratio | 0.1 |
IRadimed Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of IRadimed for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for IRadimed can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| IRadimed is unlikely to experience financial distress in the next 2 years | |
| About 37.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Why Iradimed Stock Soared Today - AOL.com |
IRadimed Fundamentals Growth
IRadimed Stock prices reflect investors' perceptions of the future prospects and financial health of IRadimed, and IRadimed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IRadimed Stock performance.
| Return On Equity | 0.25 | ||||
| Return On Asset | 0.16 | ||||
| Profit Margin | 0.27 % | ||||
| Operating Margin | 0.31 % | ||||
| Current Valuation | 1.03 B | ||||
| Shares Outstanding | 12.72 M | ||||
| Price To Book | 13.33 X | ||||
| Price To Sales | 12.84 X | ||||
| Revenue | 73.24 M | ||||
| Gross Profit | 64.32 M | ||||
| EBITDA | 27.19 M | ||||
| Net Income | 19.23 M | ||||
| Total Debt | 11.51 M | ||||
| Book Value Per Share | 6.26 X | ||||
| Cash Flow From Operations | 25.62 M | ||||
| Earnings Per Share | 1.47 X | ||||
| Total Asset | 98.33 M | ||||
| Retained Earnings | 56.79 M | ||||
About IRadimed Performance
Assessing IRadimed's fundamental ratios provides investors with valuable insights into IRadimed's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the IRadimed is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
IRadimed is entity of Germany. It is traded as Stock on STU exchange.Things to note about IRadimed performance evaluation
Checking the ongoing alerts about IRadimed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for IRadimed help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| IRadimed is unlikely to experience financial distress in the next 2 years | |
| About 37.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Why Iradimed Stock Soared Today - AOL.com |
- Analyzing IRadimed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether IRadimed's stock is overvalued or undervalued compared to its peers.
- Examining IRadimed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating IRadimed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of IRadimed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of IRadimed's stock. These opinions can provide insight into IRadimed's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for IRadimed Stock Analysis
When running IRadimed's price analysis, check to measure IRadimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRadimed is operating at the current time. Most of IRadimed's value examination focuses on studying past and present price action to predict the probability of IRadimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRadimed's price. Additionally, you may evaluate how the addition of IRadimed to your portfolios can decrease your overall portfolio volatility.